Drugs / TenofoBell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04539652 | Sep 2018 → Jun 2021 | chronic hepatitis B virus infection | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TenofoBell | “Experimental group are treated with TenofoBell®” NCT04539652 ↗ |